Halobetasol propionate and Tamsulosin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Halobetasol propionate (halobetasol propionate) and Tamsulosin (tamsulosin). Common drug interactions include drug ineffective among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Halobetasol propionate and Tamsulosin. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Halobetasol propionate?

Halobetasol propionate has active ingredients of halobetasol propionate. eHealthMe is studying from 863 Halobetasol propionate users. Check the latest studies of Halobetasol propionate.

What is Tamsulosin?

Tamsulosin has active ingredients of tamsulosin. It is often used in prostate examination abnormal. eHealthMe is studying from 72,635 Tamsulosin users. Check the latest studies of Tamsulosin.

On Jul, 09, 2026

23 people who take Halobetasol propionate and Tamsulosin together, and have interactions are studied.

Halobetasol propionate and Tamsulosin drug interactions.

What are the common drug interactions of Halobetasol Propionate and Tamsulosin, by gender? *:

female:

Drug ineffective
Discomfort
Hospitalisation
Pain
Psoriasis (immune-mediated disease that affects the skin)
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Rash
Urinary tract infection

male:

Dyspnoea (difficult or laboured respiration)
Psoriasis (immune-mediated disease that affects the skin)
Oedema (fluid collection in tissue)
Rash
Skin exfoliation (removal of the oldest dead skin cells)
Skin fissures (a crack in the skin)
Skin hyperpigmentation (disorders affect the colour of your skin)
Therapeutic response decreased (less preventive response)
Drug effect decreased
Peripheral swelling

What are the common drug interactions of Halobetasol Propionate and Tamsulosin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Discomfort
Drug ineffective
Pain
Rash

40-49:

Psoriasis (immune-mediated disease that affects the skin)
Drug effect decreased
Peripheral swelling

50-59:

Dry skin
Chronic kidney disease
Depression
Emotional distress
Hospitalisation
Pain
Renal impairment (severely reduced kidney function)
Skin discolouration (change of skin colour)
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
Pruritus (severe itching of the skin)

60+:

Urinary tract infection

What are the existing conditions these people have? *

Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 6 people, 26.09%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 21.74%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 21.74%
Immune System Disorder: 4 people, 17.39%
Skin Fissures (a crack in the skin): 2 people, 8.70%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 2 people, 8.70%

* Approximation only. Some reports may have incomplete information.

Do you take Halobetasol propionate and Tamsulosin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously